Loading clinical trials...

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis | Clinical Trials | Clareo Health

RECRUITINGNA

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

NCT06811389•Weill Medical College of Cornell University

Summary

The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educational intervention, RISE-HP, is to improve health-related quality of life in people who have hypersensitivity pneumonitis and assess feasibility and accessibility of this intervention. Patients with hypersensitivity pneumonitis (HP) experience uncertainty, feelings of anxiety and depression, and marked disruption to their lifestyle and home environment. Poor health-related quality of life (HRQOL) in HP is also driven in part by patients' profound lack of knowledge about the disease. Existing interventions for patients with HP do not target improvement in quality of life. Participants will complete either RISE-HP, a 10-session peer coach delivered behavioral and educational intervention to improve HRQOL in HP, or Staying Well, a 10-session general health education program.

Eligibility

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician.
•Age 18 or older.
•English Speaking.
•Willing to work with a peer coach.
•Have a working smart phone or tablet.
•Have access to the internet.
•Reside or live in the United States.
•Endorse verbal approval from treating physician to participate in patients' goal movement/physical activity.
•Meet one or more of the following criteria:
•Baseline score on the PHQ8 of \<20

Exclusion Criteria

•Does not have Hypersensitivity Pneumonitis
•Younger than age 18
•Severe cognitive impairment as determined by their treating physician.
•Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care.
•Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic stress disorder, or episodes of mania or psychosis.
•Anyone who is determined to be severely ill or moribund by the treating clinician.

Locations (1)

Weill Cornell Medicine

New York, New York, United States

Key Dates

Start Date

May 6, 2025

Primary Completion Date

December 1, 2026

Completion Date

December 1, 2026

Last Updated

June 18, 2025

Enrollment

ESTIMATED participants

Conditions

Hypersensitivity Pneumonitis

Interventions

Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)

BEHAVIORAL

Staying Well

BEHAVIORAL

Contacts

Anna Tharakan, BS

CONTACT

(646)962-8130 ant4034@med.cornell.edu

Alicia Morris

CONTACT

(646)962-2741 ajm2017@med.cornell.edu

Prognostic Score Comparison in IPF and HP

NCT07169253

IPFFibrotic Lung Disease+2 more

View study

COMPLETED

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

NCT04273867

Hypersensitivity PneumonitisChronic Hypersensitivity Pneumonitis+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

Inclusion Criteria

Exclusion Criteria

Prognostic Score Comparison in IPF and HP

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

HypErsensitiVity PneumonITis: DiseAse Progression Characterization

This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids.